Black Diamond Therapeutics shares owned by Cambridge Investment Research Advisors
Quarter-by-quarter ownership of Black Diamond Therapeutics (BDTX) shares owned by Cambridge Investment Research Advisors
from 13F filings
Historical chart of Cambridge Investment Research Advisors investment in Black Diamond Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Black Diamond Therapeutics held by Cambridge Investment Research Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Black Diamond Therapeutics by Cambridge Investment Research Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $245k | 65k | 3.80 |
| 2023-03-31 | $21k | 11k | 1.87 |
| 2022-12-31 | $20k | 11k | 1.78 |
| 2022-09-30 | $19k | 11k | 1.69 |
| 2022-06-30 | $28k | 11k | 2.49 |
| 2022-03-31 | $31k | 11k | 2.76 |
| 2021-12-31 | $59k | 11k | 5.35 |
More positions owned by Cambridge Investment Research Advisors
View all positions for Cambridge Investment Research Advisors